Belgium-based manufacturer of 3D printing systems, Materialise (NASDAQ: MTLS) is working with underwriters Piper Jaffray and Credit Suisse to launch its IPO. In a filing on Thursday, the company announced plans to sell eight million American Depository Shares (ADS) in the $12-$14 dollar range to raise over $110 million.
3D printer applications are useful for their ability to manufacture an array of parts for various industries, including those that are highly regulated, like medicine. In 2013, Materialise manufactured 500,000 medical devices, prototypes and production parts for the medical field. Other uses can be found in fields such as healthcare, automotive, aerospace and art and design.
For 2013, Materialise generated €68.7 million in revenue, representing 16.3 percent growth year over year. As of March 31, 2014, the company had earned €18.7 million in revenue, a 20.4 percent increase over the same period last year. After three months, Materialise has an EBITDA of €1.4 million with a net profit just in the black at €0.1 million.
Net proceeds of the offering will be used to expand 3D printing service center capacity, to increase global sales and marketing and to fund additional research and development.
Maybe this is a well-timed IPO for Materialise. Even though other publicly traded printing companies have been hammered, they are still up over 100 percent for the previous two years.